CD146 as an adverse prognostic factor in uterine sarcoma.

about

Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.Markers and Biomarkers of Endothelium: When Something Is Rotten in the State.

P2860

Q33835183-6033B2D1-004E-4897-8692-C8685D3C1D9F Q48247130-ACF0DC47-A6F9-44AD-8452-461B6B1EFE78

P2860

CD146 as an adverse prognostic factor in uterine sarcoma.

Item

http://www.wikidata.org/entity/Q35986639

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

CD146 as an adverse prognostic factor in uterine sarcoma.

@ast

CD146 as an adverse prognostic factor in uterine sarcoma.

@en

type

Item

label

CD146 as an adverse prognostic factor in uterine sarcoma.

@ast

CD146 as an adverse prognostic factor in uterine sarcoma.

@en

prefLabel

CD146 as an adverse prognostic factor in uterine sarcoma.

@ast

CD146 as an adverse prognostic factor in uterine sarcoma.

@en

P1476

CD146 as an adverse prognostic factor in uterine sarcoma.

@en

P2093

He Huang

http://www.w3.org/2001/XMLSchema#string

Jia-Xin Lin

http://www.w3.org/2001/XMLSchema#string

Lin-Jing Yuan

http://www.w3.org/2001/XMLSchema#string

Min Zheng

http://www.w3.org/2001/XMLSchema#string

Xin Huang

http://www.w3.org/2001/XMLSchema#string

Ying Xiong

http://www.w3.org/2001/XMLSchema#string

Yun Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146

The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family

MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily

Diagnosis and treatment of sarcoma of the uterus. A review.

CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer.

CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer

Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas.

CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancer

Clinical management of uterine sarcomas.

P2888

s40001-015-0160-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40001-015-0160-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281169074

http://www.w3.org/2001/XMLSchema#string

P6179

1007454736

http://www.w3.org/2001/XMLSchema#string

P698

26293576

http://www.w3.org/2001/XMLSchema#string

P932

4546164

http://www.w3.org/2001/XMLSchema#string

CD146 as an adverse prognostic factor in uterine sarcoma.

about

P2860

P2860

CD146 as an adverse prognostic factor in uterine sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932